Literature DB >> 25199750

Genotyping lung cancer is an investment in the future.

Christopher G Azzoli1, Jeffrey Engelman2, Panos Fidias2, Justin F Gainor2, Rebecca S Heist2, Elizabeth B Lamont2, Inga T Lennes2, Rachel P Rosovsky2, Lecia V Sequist2, Alice Tsang Shaw2, Jennifer S Temel2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25199750     DOI: 10.1200/JCO.2014.56.6430

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Advance in predictive and prognostic marker assessments in lung cancer.

Authors:  Mari Mino-Kenudson
Journal:  Transl Lung Cancer Res       Date:  2017-10

Review 2.  Beyond ALK and ROS1: RET, NTRK, EGFR and BRAF gene rearrangements in non-small cell lung cancer.

Authors:  Anna F Farago; Christopher G Azzoli
Journal:  Transl Lung Cancer Res       Date:  2017-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.